[MS18] Mini Symposium 18
Novel aspect of development and treatment of allergic diseases

[MS18-3] Glucagon-like peptide 1 receptor agonist treatment inhibits allergic innate immunity-induced eosinophilic and neutrophilic inflammation in a polygenic obese mouse model

Shinji Toki¹, Richard L Printz², Dawn C Newcomb^1,3, Katherine N Cahill¹, Kevin D Niswender^1,2, R Stokes Peebles Jr.^1,3 (1.Department of Medicine, Vanderbilt University Medical Center, USA, 2.Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, USA, 3.Department of Pathology, Microbiology and Immunology,, Vanderbilt University Medical Center, USA)